Drugs / DTPw-HBV/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02447432 Background | Jun 2015 → Jan 2016 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPw-HBV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02447432 ↗ |
| Modality | Vaccine | “DTPw-HBV/Hib vaccine (3 doses injected at Study Months 0, 1 and 2)” NCT02447432 ↗ |
| Route | Intramuscular | “3 doses by intramuscular injection in the left anterolateral thigh” NCT02447432 ↗ |